Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W3144346200', 'doi': None, 'title': 'Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States', 'display_name': 'Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States', 'publication_year': 2009, 'publication_date': '2009-01-01', 'ids': {'openalex': 'https://openalex.org/W3144346200', 'mag': '3144346200'}, 'language': 'zh-cn', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://www.cqvip.com/QK/84123X/200935/31963157.html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306541009', 'display_name': '世界胃肠病学杂志:英文版(电子版)', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5100704755', 'display_name': 'Muhammad Muhammad', 'orcid': 'https://orcid.org/0000-0001-9642-418X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Muhammad', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001405649', 'display_name': 'Wasif', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Wasif', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038440598', 'display_name': 'Saif', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Saif', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059872576', 'display_name': 'Nianwen', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Nianwen', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100707879', 'display_name': 'Mi Shi', 'orcid': 'https://orcid.org/0000-0002-3044-912X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Shi', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015172548', 'display_name': 'Susan Susan', 'orcid': 'https://orcid.org/0000-0002-0924-8200'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Susan', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5046498094', 'display_name': 'Zelt', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Zelt', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 64}, 'biblio': {'volume': None, 'issue': '35', 'first_page': '4415', 'last_page': '4422'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10696', 'display_name': 'Gastric Cancer Research and Treatment', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10696', 'display_name': 'Gastric Cancer Research and Treatment', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11067', 'display_name': 'Advancements in Colorectal Cancer Research', 'score': 0.9966, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T14078', 'display_name': 'Epidemiology of Multiple Primary Cancers', 'score': 0.9961, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/clinical-characteristics', 'display_name': 'Clinical Characteristics', 'score': 0.492039}], 'concepts': [{'id': 'https://openalex.org/C2777909004', 'wikidata': 'https://www.wikidata.org/wiki/Q420207', 'display_name': 'Capecitabine', 'level': 4, 'score': 0.99905336}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.64154035}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5232448}, {'id': 'https://openalex.org/C2780456651', 'wikidata': 'https://www.wikidata.org/wiki/Q238512', 'display_name': 'Fluorouracil', 'level': 3, 'score': 0.48587412}, {'id': 'https://openalex.org/C2777844706', 'wikidata': 'https://www.wikidata.org/wiki/Q422504', 'display_name': 'Deoxycytidine', 'level': 4, 'score': 0.453705}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.40746626}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.36581925}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.25601372}, {'id': 'https://openalex.org/C2780258809', 'wikidata': 'https://www.wikidata.org/wiki/Q414143', 'display_name': 'Gemcitabine', 'level': 3, 'score': 0.060597092}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://www.cqvip.com/QK/84123X/200935/31963157.html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306541009', 'display_name': '世界胃肠病学杂志:英文版(电子版)', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': [], 'abstract_inverted_index': {'瞄准:为了估计基于': [0], 'capecitabine': [1, 27, 29, 35, 43, 49, 58], '的治疗和联系复杂并发症的使用,在一个真实世界的治疗背景与胃的食道的癌症(GEC': [2], ')': [3, 17], '在病人评价。方法:有在': [4], '2004': [5], '和': [6], '2005': [7], '之间的主张的病人从': [8], 'Thomson': [9], '路透社': [10], 'MarketScan': [11], '(R)': [12], '数据库被识别。Capecitabine': [13], '政体与': [14], '5': [15], '氟尿嘧啶(5-FU': [16], '和另外的化疗政体相比,并且被治疗设定成层。结果:我们与': [18], 'GEC': [19, 63], '识别了': [20], '1013': [21], '个病人:近似,一半把治疗与': [22], '5-FU': [23, 37, 47, 54, 56, 61], '政体开始了,而': [24], '11%': [25], '把治疗与': [26], '政体开始了。吝啬的': [28], '剂量外套是': [30], '2382': [31], '+/-': [32], '1118': [33], 'mg/d,和': [34], '更经常被用作单音的治疗比在里面联合。总的来说,': [36], '政体是在': [38], 'neoadjuvant': [39], '和辅助背景的最普通的治疗选择,当另外的': [40], 'non-capecitabine': [41], '政体在首要、第二线的背景更广泛地被使用时。为': [42], '政体的全面': [44], 'unadjusted': [45], '复杂并发症率与': [46], '政体就那的一半被看见。在里面多,变量分析,有的': [48], '接受者一': [50], '51%(95%': [51], 'CI:26%-81%)': [52], '比': [53], '接受者开发任何复杂并发症的更低的风险做了。开发骨头髓的风险,宪政的、胃肠的道,传染,或皮肤复杂并发症比与': [55], '与': [57], '治疗是更低的。结论:Capecitabine': [59], '看起来与': [60], '相比有有利副作用侧面,它显示它可以是为': [62], '的一种治疗选择。': [64]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3144346200', 'counts_by_year': [], 'updated_date': '2024-09-19T12:27:16.170659', 'created_date': '2021-04-13'}